AMANDA EDGAR: Open Payments
NPI 1710486808 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,373 in 47 payments from 12 companies in 2025. Trend: 2023 $947 · 2024 $5,243 · 2025 $1,373
Food & beverage: $923Honoraria: $450
| Company | Payments | Amount |
|---|---|---|
| SCPHARMACEUTICALS INC. | 3 | $526 |
| Novartis Pharmaceuticals Corporation | 13 | $286 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $139 |
| Abbott Laboratories | 6 | $115 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $93 |
| E.R. Squibb & Sons, L.L.C. | 4 | $62 |
| Alnylam Pharmaceuticals Inc. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| AtriCure, Inc. | 1 | $26 |
| Kestra Medical Technology Services, Inc. | 1 | $22 |
Products named: FUROSCIX, LEQVIO, LifeVest, CARDIOMEMS, Kerendia, AMVUTTRA, JARDIANCE, CAMZYOS.
Industry payments across MS — which companies pay providers there.
